Clinical trial · Observational
Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf
Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overall aim of the study is: To provide accurate and reliable information regarding NSCLC clinical management across MENA region in order to detect unmet medical needs of this disease in terms of: * Patient and hospital characteristics. * Diagnostic and treatment approaches: initial and subsequent. * Follow-up patterns in clinical management. * Outcomes: symptoms, death, functionality, quality of life. * Use of resources and burden on patients and health care systems.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non Small Cells Lung Cancer | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- All Population
- label
- Sample of patients will be invited to complete Quality of Life
Primary outcomes (1)
- measure
- Use of health resources by collecting data about hospital description and characteristics, Disease Diagnosis Procedures and Therapy information
- timeFrame
- April 2014(26 Months)
Secondary outcomes (1)
- measure
- Patient-Reported Outcomes (PRO) through self-administered questionnaires and the patients will be asked to complete them at each evaluation visit(25% of the whole sample)
- timeFrame
- April 2014(26 Months)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women, attending the responsible department of treating this type of patients for the first time between November 1st, 2011 and August 30th, 2012 For PRO * Sub-sample: * ability to read and write since they will be asked to participate in the PRO part of the study. * Selection will not be based on the disease stage of each patient, in order to avoid a selection bias. Exclusion Criteria: * According to the study design there will not be any exclusion criteria in order to provide a high validity and to obtain the most accurate real daily practice information.
References
Publications (0)
Data not yet available